Unclassified

Randomized Trials in Pregnancy—Reply | ClinicLens

In Reply I believe RCTs should be routinely used for evaluating drug safety and efficacy during pregnancy, just as they are for nonpregnant individuals. While I agreed in my Viewpoint that observational studies may complement RCTs in detecting rare adverse effects, the broader co

Medical Literature · Updated

← Back to articles
This standalone article is served from the ClinicLens content archive.

If the embedded page does not load in your browser, open it directly.